Shanghai Xuerong Biotechnology Co.,Ltd. (SHE:300511)
China · Delayed Price · Currency is CNY 7.01
-0.07 (-0.99%)
At close: Feb 13, 2026
SHE:300511 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | -515.61 | -617.07 | -188.06 | -287.23 | -311.59 | 230.41 |
Depreciation & Amortization | 373.92 | 373.92 | 324.76 | 341.34 | 314.26 | 322.32 |
Other Amortization | 5.13 | 5.13 | 9.75 | 8.97 | 9.97 | 8.52 |
Loss (Gain) From Sale of Assets | -7.85 | -7.85 | 6.46 | 8.42 | 18.4 | 1.68 |
Asset Writedown & Restructuring Costs | 428.65 | 428.65 | 62.46 | 402.89 | 194.12 | 28.68 |
Loss (Gain) From Sale of Investments | 0.65 | 0.65 | 2.65 | -8.87 | -1.01 | -4.01 |
Other Operating Activities | 10.03 | 97.82 | 83.21 | -17.7 | 43.66 | 49.57 |
Change in Accounts Receivable | 11.8 | 11.8 | 4.74 | 11.16 | -6.06 | 3.71 |
Change in Inventory | 73.99 | 73.99 | -58.19 | -89.3 | -57.64 | -63.86 |
Change in Accounts Payable | 70.16 | 70.16 | 115.93 | 9.04 | 43.3 | -37.33 |
Change in Other Net Operating Assets | - | - | -5.87 | -24.41 | 1.67 | 19.02 |
Operating Cash Flow | 450.87 | 437.2 | 357.84 | 367.13 | 244.06 | 555.47 |
Operating Cash Flow Growth | 19.73% | 22.18% | -2.53% | 50.43% | -56.06% | -5.36% |
Capital Expenditures | -83.92 | -327.46 | -1,097 | -319.47 | -637.19 | -482.79 |
Sale of Property, Plant & Equipment | 19.81 | 18.13 | 69.23 | 88.28 | 60.6 | 8.69 |
Divestitures | - | - | - | 78 | - | - |
Sale (Purchase) of Real Estate | - | - | - | - | - | -40 |
Investment in Securities | -0.75 | - | 271.05 | -272 | -20 | -9.48 |
Other Investing Activities | 0.01 | - | 1.51 | 1.99 | 1.89 | - |
Investing Cash Flow | -64.85 | -309.33 | -755.24 | -423.21 | -594.7 | -523.58 |
Short-Term Debt Issued | - | 18 | - | 11.52 | 3.89 | - |
Long-Term Debt Issued | - | 1,165 | 1,201 | 910.94 | 927.61 | 926.44 |
Total Debt Issued | 469 | 1,183 | 1,201 | 922.46 | 931.49 | 926.44 |
Long-Term Debt Repaid | - | -1,242 | -902.45 | -1,207 | -914.41 | -942.96 |
Net Debt Issued (Repaid) | -423.77 | -58.31 | 299 | -284.12 | 17.09 | -16.52 |
Issuance of Common Stock | 0.47 | - | - | 386.73 | - | 628.35 |
Repurchase of Common Stock | -28 | -28 | -13.92 | -20.2 | -1.74 | - |
Common Dividends Paid | -60.21 | -67.01 | -60.32 | -58.73 | -102.59 | -115.86 |
Other Financing Activities | 67.13 | 16.89 | -20.1 | 43.42 | 18.75 | -34.07 |
Financing Cash Flow | -444.37 | -136.42 | 204.65 | 67.1 | -68.5 | 461.9 |
Foreign Exchange Rate Adjustments | -3 | 0.53 | 0.15 | 0.16 | -1.36 | -1.62 |
Net Cash Flow | -61.35 | -8.02 | -192.6 | 11.18 | -420.49 | 492.17 |
Free Cash Flow | 366.95 | 109.74 | -739.19 | 47.66 | -393.13 | 72.68 |
Free Cash Flow Growth | - | - | - | - | - | -73.53% |
Free Cash Flow Margin | 19.88% | 5.08% | -28.82% | 2.05% | -18.96% | 3.30% |
Free Cash Flow Per Share | 0.67 | 0.22 | -1.49 | 0.10 | -0.91 | 0.17 |
Cash Income Tax Paid | 24.83 | 26.76 | 21.17 | 22.17 | 19.24 | 15.52 |
Levered Free Cash Flow | 337.29 | -46.93 | -490.08 | -63.88 | -654.65 | -53.1 |
Unlevered Free Cash Flow | 379.87 | 14.45 | -434.6 | -5.78 | -606.46 | -8.31 |
Change in Working Capital | 155.95 | 155.95 | 56.61 | -80.69 | -23.75 | -81.71 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.